Research Overview of HGH Fragment 176-191
HGH Fragment 176-191 is a synthetic peptide comprising the amino acid sequence 176-191 from the C-terminal region of human growth hormone. This modified peptide fragment represents approximately 16 amino acids from the original hGH molecule and has become a focal point for metabolic research applications. Research scientists examining adipose tissue metabolism often investigate this compound for its structural properties and potential interactions with cellular mechanisms. The Sterling Knight formulation provides researchers with a standardised 10mg vial suitable for controlled laboratory investigations. Studies conducted at Stroid UK Shop have demonstrated interest in this peptide’s unique molecular characteristics compared to full-length growth hormone sequences.
Laboratory Applications and Research Protocols
Research applications for HGH Fragment 176-191 primarily focus on cellular metabolism studies and adipose tissue research. Laboratory protocols typically examine the compound’s interaction with lipolytic pathways and its effects on cellular energy utilisation mechanisms. Researchers investigating metabolic modulation often include this fragment in comparative studies with other research peptides to understand structural-functional relationships. The 10mg presentation allows for precise reconstitution and dilution protocols essential for reproducible experimental conditions. Many research institutions examine this compound alongside traditional growth hormone studies to evaluate selective receptor binding properties. The peptide’s shorter chain length compared to full hGH makes it valuable for structure-activity relationship investigations in endocrinology research. Studies frequently explore the compound’s stability characteristics and storage requirements for long-term research projects. Advanced metabolic research programs often incorporate this fragment when examining cellular signalling pathways related to lipid metabolism. Comparative studies with selective androgen receptor modulators provide researchers with comprehensive metabolic pathway data.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Verify with supplier |
| Purity | ≥98% (HPLC verified) |
| Appearance | White lyophilised powder |
| Storage | -20°C (dry powder) |
| Solubility | Water, bacteriostatic water |
| CAS Number | Verify with supplier |
Research Compliance Information
HGH Fragment 176-191 10mg Sterling Knight is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any clinical applications. Research institutions must ensure proper handling protocols and storage conditions are maintained throughout investigational studies. All research must comply with relevant laboratory safety guidelines and institutional research ethics requirements.
